glp-1 resources Resource Center A Guide to GLP-1s: Resources

Based on community reports: What users commonly report: Reduced inflammation and redness (24 weeks) Slower lesion progression Improved healing of cracked/bleeding plaques Better response to other treatments when stacked What peptides likely won't do: Completely clear severe psoriasis Replace biologics for moderate-to-severe cases Work immediately (expect 48 week timeline) Protocol Considerations Starting a Peptide Protocol for Psoriasis Get a baseline: Document current lesion coverage (photos, PASI score if available) Start with one peptide: GHK-Cu or BPC-157 alone for 24 weeks Add sequentially: This lets you identify what's helping Track consistently: Weekly photos, symptom diary Sample Stack (Not Medical Advice) Conservative approach: GHK-Cu 1 mg subQ daily (skin repair focus) BPC-157 250 mcg subQ daily (anti-inflammatory) Duration: 8 weeks, then reassess More aggressive approach (for those comfortable with peptides): KLOW blend per dosing guide (covers BPC/TB/GHK) Add KPV 200 mcg if available (NF-B focus) Duration: 812 weeks Complementary Strategies Peptides work best alongside foundational approaches: Diet: Anti-inflammatory diet, reduce processed foods Vitamin D: Optimize levels (psoriasis has strong Vitamin D connection) Omega-3s: High-dose fish oil (24g EPA/DHA) Stress management: Psoriasis flares with cortisol Topicals: Continue prescribed treatments Frequently Asked Questions Q: Can I use peptides while on biologics (Humira, Skyrizi, etc.)

Popular among celebrities, beauty enthusiasts, and wellness seekers, glutathione infusions are praised for their potential to lighten skin tone, reduce pigmentation, and deliver a powerful antioxidant boost

Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria

"And, I believe they're being held back from the people of North Carolina when they could be providing a great deal of value here in the buckle of the Barbecue Belt." Kinsley told lawmakers that the drugs would help prevent health conditions associated with obesity, such as heart attack, stroke and diabetes

Study: Real-world evaluation of clinical outcomes in Dutch patients with type 2 diabetes treated with oral semaglutide: A retrospective, observational cohort study using the PHARMO data network